Status:
COMPLETED
A Computational Approach to Optimal Deactivation of Cochlear Implant Electrodes
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Hearing Loss
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The goal of the present study is to use computationally driven models of speech understanding in cochlear implant (CI) users to guide the search for which combination of active electrodes can yield th...
Detailed Description
Aim 1 is to quantify speech understanding and sound quality with model-recommended combinations of active electrodes compared to standard settings, and compared to two control active electrode combina...
Eligibility Criteria
Inclusion
- Cochlear implant subjects
- must be older than the age of 18
- implanted unilaterally with CI with at least 1 year of experience
- no diagnosis of any other communicative or cognitive disorder.
- English-speaking
- willingness and ability to provide informed consent
- Normal hearing subjects
- must be older than age of 18
- no diagnosis of any other communicative or cognitive disorder.
- English-speaking
- willingness and ability to provide informed consent
Exclusion
- not meeting the inclusion criteria above
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05219474
Start Date
May 1 2022
End Date
April 30 2025
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016